mutual funds as our laboratory. We provide evidence consistent with product differentiation,
reflected in fund prospectuses, enabling low-performing funds to compete for customers and
charge higher fees by offering more niche products. Exploiting the issuance of Morningstar
rating as a shock to perceived quality, we establish a causal link between low quality and
increased differentiation. Funds receiving a low rating actively change their prospectus …